Litcius/Paper detail

Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations

Francesco Paolo Tambaro, William G. Wierda

2020The Lancet Haematology33 citationsDOI

Topics & Concepts

Tumor lysis syndromeMedicineVenetoclaxChronic lymphocytic leukemiaChemotherapyComplicationInternal medicineLeukemiaLymphomaAcute lymphocytic leukemiaImmunologyOncologyLymphoblastic LeukemiaMethemoglobinemia and Tumor Lysis SyndromeNeonatal Health and BiochemistryChronic Lymphocytic Leukemia Research
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations | Litcius